Cyclic AMP and malignant glioma. 1. Effects of dibutyryl adenosine cyclic 3',5'-monophosphate on malignant glioma cells
Kanno, T.; Nakazawa, T.; Kato, Y.
Rinsho Shinkeigaku 12(11): 584-595
1972
ISSN/ISBN: 0009-918X PMID: 4345680 Document Number: 48577
Document emailed within 1 workday
Related Documents
Yamasaki, Y.; Fujiwara, M.; Toda, N. 1974: Effects of intracellularly applied cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on the electrical activity of sinoatrial nodal cells of the rabbit Journal of Pharmacology and Experimental Therapeutics 190(1): 15-20Kanno, T.; Nakazawa, T.; Kato, Y. 1973: Cyclic AMP and malignant glioma. II. Effects of cyclic AMP on the growth of glial tumors Rinsho Shinkeigaku 13(11): 726-731
Wilson, D.F. 1974: The effects of dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline and aminophylline on neuromuscular transmission in the rat Journal of Pharmacology and Experimental Therapeutics 188(2): 447-452
Huot, R.I.; Nardone, R.M.; Stromberg, K. 1987: Differential modulation of human chorionic gonadotropin production by methotrexate in normal and malignant placental cultures and its increase by dibutyryl cyclic adenosine monophosphate and/or actinomycin D in normal cultures Cancer Research 47(2): 383-387
Pepe, S.; Tortora, G.; Noguchi, P.D.; Marti, G.E.; Washington, G.C.; Cho-Chung, Y.S. 1991: Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells Cancer Research 51(23 Part 1): 6263-6267
Wu, J.; Wang, D.; Dai, X.; Wang, Z.; Liu, B.; Lu, Z.; Wang, A.; Dong, J.; Lan, Q.; Huang, Q. 2014: Malignant transformation of glioma stromal cells induced by glioma stem cells heterotopically inoculated in host liver Zhonghua Yi Xue Za Zhi 94(35): 2775-2780
Nedvídková, J.; Felt, V. 1984: Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies Casopis Lekaru Ceskych 123(27): 835-837
Polson, J.B.; Krzanowski, J.J.; Szentivanyi, A. 1974: Histamine induced changes in pulmonary guanosine-3',5'-cyclic monophosphate (cGMP) and adenosine-3',5'-cyclic monophosphate (cAMP) levels in mice following sensitization by Bordetella pertussis and/or propranolol Research Communications in Chemical Pathology and Pharmacology 9(2): 243-251
Winkert, J.; Birchette, C.; Wilson, M. 1971: Augmentation of erythrocyte iron uptake in post-hypoxic mice by the administration of N 6 , O 2 '- -dibutyryl cyclic adenosine 3',5'-monophosphate (dBcAMP) 1,2,3 Research Communications in Chemical Pathology and Pharmacology 2(3): 323-329
Wildenthal, K. 1974: Studies of fetal mouse hearts in organ culture: influence of prolonged exposure to triiodothyronine on cardiac responsiveness to isoproterenol, glucagon, theophylline, acetylcholine and dibutyryl cyclic 3',5'-adenosine monophosphate Journal of Pharmacology and Experimental Therapeutics 190(2): 272-279
Vocci, F.J.; Welch, S.P.; Dewey, W.L. 1980: Differential effects of divalent cations, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3': 5'-cyclic monophosphate antinociception Journal of Pharmacology and Experimental Therapeutics 214(3): 463-466
Katz, A.M. 1990: Interplay between inotropic and lusitropic effects of cyclic adenosine monophosphate on the myocardial cell Circulation 82(2): I7-11
Vesin, M.F.; Harbon, S. 1974: The effects of epinephrine, prostaglandins, and their antagonists on adenosine cyclic 3',5'-monophosphate concentrations and motility of the rat uterus Molecular Pharmacology 10(3): 457-473
Oleson, D.R.; DeFelice, L.J.; Quinn, M.F.; Donahoe, R.M. 1996: Cyclic adenosine 3',5'-monophosphate increases the open probability of potassium channels in activated human T cells Journal of Immunology 157(3): 1080-1086
Nikulin, A.A. 1978: Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets Farmakologiia i Toksikologiia 41(2): 177-182
Boĭchenko, M.N.; Aniskin, E.D. 1976: Elaboration of chloramphenicol acetyltransferase by cells of E. coli K-12 under conditions altering the intracellular concentration of cyclic adenosine-3',5'-monophosphate Biulleten' Eksperimental'noi Biologii i Meditsiny 81(3): 294-295
Rovin, B.H.; Tan, L.C.; Leonhart, K.L.; Nahman, N.S. 1995: Cyclic adenosine monophosphate and protein kinase C modulate fibronectin production in cultured human mesangial cells Journal of Laboratory and Clinical Medicine 126(2): 216-223
Zaremba, T.G.; Fishman, P.H. 1984: Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis Molecular Pharmacology 26(2): 206-213
Chen, H.; Huang, Q.; Zhai, D-zhong.; Dong, J.; Wang, A-dong.; Lan, Q. 2007: CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells Zhonghua Zhong Liu Za Zhi 29(7): 484-488
Shimizu, K.; Yamada, M.; Mabuchi, E.; Matsui, Y.; Tamura, K.; Moriuchi, S.; Park, K.; Mogami, H. 1989: Antitumor efficacy of FK 973 on malignant glioma cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(7): 2367-2372